The role of data mining in pharmacovigilance

M Hauben, D Madigan, CM Gerrits… - Expert opinion on …, 2005 - Taylor & Francis
A principle concern of pharmacovigilance is the timely detection of adverse drug reactions
that are novel by virtue of their clinical nature, severity and/or frequency. The cornerstone of …

Perspectives on the use of data mining in pharmacovigilance

…, N Yuen, V Patadia, M Blum, M Johnston, C Gerrits… - Drug safety, 2005 - Springer
… with ‘S only’ compared with ‘S + C’ and that a greater number of drug-event pairs meet or
exceed a numerical ‘signal’ threshold with ‘S only’ compared with ‘S + C’. However, there are …

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development

CJH Gerrits, MJA De Jonge, JHM Schellens… - British journal of …, 1997 - nature.com
Topoisomerase I inhibitors constitute a new class of anti-cancer agents. Recently, topotecan
and irinotecan were registered for clinical use in ovarian cancer and colorectal cancer …

Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or …

JE Signorovitch, EQ Wu, AP Yu, CM Gerrits… - …, 2010 - Springer
… drug C (RR A:C ) and another trial provides the relative response rate of drug B versus … C
(RR B:C ), the relative response rate of drug A versus drug B is estimated as RR A:C /RR B:C . …

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease

C Gerrits, RMC Herings, HGM Leufkens… - European …, 2003 - Eur Respiratory Soc
The aim of this study was to evaluate the effect of oral N‐acetylcysteine in the prevention of
re-hospitalisation for chronic obstructive pulmonary disease (COPD) exacerbations. Using …

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis

…, H Wang, H Chung, Q Zhang, E Wu, C Gerrits - BMJ open, 2016 - bmjopen.bmj.com
c Two articles analysed the same trial. d Conferences searched included EASD and ADA
2011–2013, and IDF 2011. IDF 2013 was assessed when the CD-ROM became available—…

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

CM Gerrits, M Bhattacharya, S Manthena… - … and drug safety, 2007 - Wiley Online Library
Background Recent studies have raised concerns about potential increased cardiovascular
(CV) risk in type 2 diabetes patients treated with some peroxisome proliferator‐activated …

Delays in pulmonary decline in eteplirsen‐treated patients with Duchenne muscular dystrophy

J Iff, C Gerrits, Y Zhong, E Tuttle, E Birk… - Muscle & …, 2022 - Wiley Online Library
Introduction/Aims Pulmonary decline is a major issue in patients with Duchenne muscular
dystrophy (DMD). Eteplirsen is a United States–approved treatment for patients with DMD and …

[HTML][HTML] Persistence with inhaled corticosteroid therapy in daily practice

NS Breekveldt-Postma, C Gerrits, JWJ Lammers… - Respiratory …, 2004 - Elsevier
Objective: To quantify persistence with inhaled corticosteroids (ICS) among new users in
daily practice and identify determinants of persistence. Methods: A retrospective cohort study …

Restoration of infiltration capacity of permeable pavers

C Gerrits, W James - Global Solutions for Urban Drainage, 2002 - ascelibrary.org
The restoration of the infiltration capacity of permeable pavers is covered and the hypothesis
that permeable paver infiltration capacities decrease with age and increased traffic use is …